Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

KRYS – krystal biotech, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KRYS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/18
12:58 pm
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
2/18
12:58 pm
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
2/18
07:55 am
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
2/18
07:18 am
krys
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low Report
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Report
2/17
02:19 pm
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
2/17
02:19 pm
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
2/2
12:50 pm
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
2/2
12:50 pm
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
2/2
12:50 pm
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
1/12
03:54 pm
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
1/12
03:54 pm
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
1/9
10:18 am
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
1/9
10:18 am
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
1/9
07:18 am
krys
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium Report
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Report
1/6
08:20 am
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
1/6
08:20 am
krys
Rating for KRYS
Low Report
Rating for KRYS
Report
1/6
08:02 am
krys
Krystal Biotech (NASDAQ:KRYS) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Low Report
Krystal Biotech (NASDAQ:KRYS) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Report
1/6
06:15 am
krys
Krystal Biotech upgraded to Buy from Neutral at Citi
Low Report
Krystal Biotech upgraded to Buy from Neutral at Citi
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0